Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma

Abstract

Despite disparate molecular pathways driving the progression of glioblastoma, metabolic programs designed to maintain its aggressive phenotype remain conserved. This contributes to a state of enhanced metabolic heterotrophy supporting survival in diverse microenvironments implicit in this malignancy.